Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Gene Therapy

• Publication date

  2009-06-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gt.2009.72PMID 19494843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A. Commentary

  2020cited by this paper
• E1A- and E1B-Double Mutant Replicating Adenovirus Elicits Enhanced Oncolytic and Antitumor Effects

  2007cited by this paper
• Cardiolipin-specific peroxidase reactions of cytochrome C in mitochondria during irradiation-induced apoptosis.

  2007cited by this paper
• AdΔ24 and the p53‐expressing variant AdΔ24‐p53 achieve potent anti‐tumor activity in glioma when combined with radiotherapy

  2007cited by this paper
• AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.

  2007cited by this paper
• Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.

  2007cited by this paper
• Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

  2006cited by this paper
• Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin

  2006cited by this paper
• CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.

  2006cited by this paper
• Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity

  2005cited by this paper
• Ionizing Radiation-Induced Adenovirus Infection Is Mediated by Dynamin 2

  2005cited by this paper
• ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis

  2005cited by this paper
• Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.

  2004cited by this paper
• Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.

  2004cited by this paper
• [Molecular and cellular mechanisms of the low intensity laser radiation effect].

  2004cited by this paper
• Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer

  2004cited by this paper
• Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts.

  2003cited by this paper
• Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

  2003cited by this paper
• Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.

  2003cited by this paper
• ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells.

  2003cited by this paper
• Replicative Oncolytic Adenoviruses in Multimodal Cancer Regimens

  2003cited by this paper
• Radiation and ceramide-induced apoptosis

  2003cited by this paper
• ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.

  2002cited by this paper
• Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy

  2002cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• Radiotherapy-related fatigue.

  2002cited by this paper
• Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

  2002cited by this paper
• A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.

  2001cited by this paper
• Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.

  2001cited by this paper
• Radiotherapy-related Fatigue: How to Assess and how to Treat the Symptom. A Commentary

  2001cited by this paper
• CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.

  2001cited by this paper
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

  2000cited by this paper
• In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.

  2000cited by this paper
• Enhancement of tumor radioresponse in vivo by gemcitabine.

  1999cited by this paper
• A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and Radiotherapy

  1998cited by this paper
• The future of gene therapy in the treatment of urologic malignancies.

  1998cited by this paper
• Signaling in and regulation of ionizing radiation-induced apoptosis in endothelial cells.

  1998cited by this paper
• Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death

  1997cited by this paper
• Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.

  1994cited by this paper
• Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.

  1994cited by this paper
• Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells

  1994cited by this paper

• Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements

  2022cites this paper
• GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment

  2021cites this paper
• Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity

  2020cites this paper
• Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis

  2017cites this paper
• A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth

  2015cites this paper
• ONCOLYTIC ADENOVIRUS CODING FOR GM-CSF IN TREATMENT OF CANCER

  2015cites this paper
• Combining oncolytic immunotherapy with conventional cancer treatments

  2015cites this paper
• Oncolytic adenoviruses: A thorny path to glioma cure

  2014cites this paper
• CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo

  2014cites this paper
• Phosphatidylinositol 3-kinase signaling as a therapeutic target for cervical cancer.

  2013cites this paper
• 2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells

  2013cites this paper
• The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model

  2013cites this paper
• A conditionally replicating adenovirus carrying interleukin‐24 sensitizes melanoma cells to radiotherapy via apoptosis

  2012cites this paper
• Influence of HPV16 E6/7 on the Expression of FGF2 and FGFR Type B in Cervical Carcinogenesis

  2012cites this paper
• Molecular characterization of apoptosis induced by CARF silencing in human cancer cells

  2011cites this paper
• The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma

  2011cites this paper
• A Novel Conditionally Replicating “Armed” Adenovirus Selectively Targeting Gastrointestinal Tumors with Aberrant wnt Signaling

  2011cites this paper
• Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy.

  2010cites this paper
• Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo.

  2010cites this paper
• Adenoviral Gene Therapy for Advanced Head and Neck Cancer

  2010cites this paper
• Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.

  2010cites this paper